An evaluation of pharmacotherapy for exercise-induced asthma.
D000284:Administration, Oral; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy*; D001250:Asthma, Exercise-Induced / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010366:Peak Expiratory Flow Rate; D013806:Theophylline / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000336:Aerosols; D010276:Parasympatholytics; D013806:Theophylline